Skip to content
value.today

Pluri Inc.

PLUR
$15 Mmarket cap on Oct 29, 2026-41.6% since Jan 2024
Compare
World rank
#25,017
Revenue
$1 M
For year ending June-2026
Net income
$-24 M
-2335.3% margin
SEC filing
Employees
92
As of June 30, 2026
SEC filing

Pluri Inc. in brief

Pluri Inc. is a listed company in the Biotechnology industry, based in Israel. Its market value was $15 M on 29 October 2026, which makes it the 25,017th largest listed company in the world and the 260th largest in Israel on this site. In the year to June 2026 it had sales of $1 M and a net loss of $24 M. It employs about 92 people and Yaky Yanay is its chief executive. Its shares trade under the symbol PLUR (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Pluri Inc.

We are a biotechnology company leveraging our proprietary 3D cell expansion platform, which is supported by an in-house, industrial-scale cell manufacturing facility and operates in accordance with Good Manufacturing Practice standards on a self-declared basis. Our platform is designed to enable scalable, cost-efficient and reproducible expansion of human, plant and animal cells and supports cell-based products, services, therapeutics and related technologies across two primary application areas: (i) Human Health and Longevity and (ii) Foodtech and Bio-Farming.

We were incorporated in Nevada on May 11, 2001. Pluri Inc. has a wholly owned subsidiary, Pluri Biotech Ltd., which is incorporated under the laws of the State of Israel.

From the company's annual report filed with the US SEC: read the report

Pluri Inc. timeline

5 events, 2001–2025
  1. 2001
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2003
  4. ✎
    Renamed Pluristem Life Systems Inc
    Formerly Ai Software Inc.
  5. 2007
  6. ✎
    Renamed Pluristem Therapeutics Inc
    Formerly Pluristem Life Systems Inc.
  7. 2022
  8. ✎
    Renamed Pluri Inc.
    Formerly Pluristem Therapeutics Inc.
  9. 2025
  10. 💰
    Record revenue of $1 million
    FY2025, the highest of the 8 years on record.

Events of Pluri Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$9 M$18 M$27 M$36 M2023202420252026

World rank over time

▲ up 2,186 places since 2022
2022-12-25: #27229#27,22920222023-07-30: #27402#27,40220232024-01-05: #27868#27,86820242026-03-08: #11495#11,49520262026-08-01: #21885#21,88520262026-10-29: #25043#25,0432026

Rank in Israel: #341 (Dec 2022) · #373 (Jul 2023) · #379 (Jan 2024) · #42 (Mar 2026) · #257 (Aug 2026) · #260 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
10.4×
Price / book
—
Free cash flow yield
-133.2%
Net margin (TTM)
-1942.5%
Operating margin
-2445.1%
Return on equity
—
Liabilities / assets
170.1%
Revenue growth
-23.9%
R&D / revenue
1479.4%
Revenue per employee
$11 K
Profit per employee
$-259 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Jun 2019: revenue $0M, net income $-35M$0MFY19Fiscal year ending Jun 2020: revenue $0M, net income $-29M$0MFY20Fiscal year ending Jun 2021: revenue —, net income $-50M—FY21Fiscal year ending Jun 2022: revenue $0M, net income $-41M$0MFY22Fiscal year ending Jun 2023: revenue $0M, net income $-28M$0MFY23Fiscal year ending Jun 2024: revenue $0M, net income $-21M$0MFY24Fiscal year ending Jun 2025: revenue $1M, net income $-23M$1MFY25Fiscal year ending Jun 2026: revenue $1M, net income $-24M$1MFY26
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Jun 2026$1M-23.9%$-25M$-24M-2335.3%
Jun 2025$1M+306.1%$-22M$-23M-1685.1%
Jun 2024$0M+13.8%$-22M$-21M-6330.3%
Jun 2023$0M+26.1%$-27M$-28M-9765.5%
Jun 2022$0M—$-42M$-41M-17930.4%
Jun 2021——$-51M$-50M—
Jun 2020$0M-60.0%$-29M$-29M-145750.0%
Jun 2019$0M—$-36M$-35M-70620.0%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Jun 2026$-20M$1M$-20M$-2.44—
Jun 2025$-18M$2M$-20M$-3.56—
Jun 2024$-18M$0M$-18M$-3.99—
Jun 2023$-23M$0M$-23M$-6.24—
Jun 2022$-37M$0M$-37M$-1.28—
Jun 2021$-31M$0M$-31M$-1.77—
Jun 2020$-26M$0M$-27M$-1.60—
Jun 2019$-29M$0M$-30M$-2.90—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$1M
Net income, trailing 12 months
$-28M
RevenueNet income
Three months to Dec 2024: revenue $0M, net income $-3M$0MDec ’24Three months to Mar 2025: revenue $0M, net income $-6M$0MMar ’25Three months to Jun 2025 (from the annual report): revenue $0M, net income $-8M$0MJun ’25Three months to Sep 2025: revenue $0M, net income $-6M$0MSep ’25Three months to Dec 2025: revenue $0M, net income $-7M$0MDec ’25Three months to Mar 2026: revenue $0M, net income $-6M$0MMar ’26Three months to Jun 2026 (from the annual report): revenue $0M, net income $-6M$0MJun ’26Three months to Sep 2026: revenue $1M, net income $-10M$1MSep ’26

Latest quarter to Sep 2026: revenue $1M (+137.5% on a year earlier), net income $-10M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Pluri Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$1 M
Operating income
$-25 M
Net income
$-24 M

For year ending June-2026 · source: SEC filing

Balance sheet

Total assets
$25 M
Total liabilities
$42 M
Total equity
$-23 M

As of June-2026

Top 18 institutional investors in Pluri Inc.#

As of Sep 30, 2026
18 institutions held 1.3 M shares (about 10.3% of the shares outstanding) on Sep 30, 2026. The ten largest hold 10.3%. Source: SEC Form 13F filings, filed through Nov 16, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 18 largest institutional investors in Pluri Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Armistice Capital, LLC1,200,077New9.72%$1 MNov 16, 2026
2Citadel Advisors LLC46,164New0.37%$0 MNov 16, 2026
3Renaissance Technologies LLC16,056-2,268 (-12.38%)0.13%$0 MNov 12, 2026
4Morgan Stanley2,9820 (0.00%)0.02%$0 MNov 13, 2026
5EverSource Wealth Advisors, LLC2,0000 (0.00%)0.02%$0 MNov 4, 2026
6UBS Group AG504-1,414 (-73.72%)0.00%$0 MNov 10, 2026
7Barclays PLC366New0.00%$0 MNov 6, 2026
8SIMA Wealth Partners, LLC3500 (0.00%)0.00%$0 MOct 19, 2026
9Wells Fargo & Company/mn1850 (0.00%)0.00%$0 MNov 16, 2026
10Jpmorgan Chase & Co1250 (0.00%)0.00%$0 MNov 12, 2026
11Royal Bank Of Canada1250 (0.00%)0.00%$0 MNov 16, 2026
12SBI Securities Co., Ltd.970 (0.00%)0.00%$0 MOct 22, 2026
13TD Waterhouse Canada Inc.93-2 (-2.11%)0.00%$0 MOct 16, 2026
14Activest Wealth Management860 (0.00%)0.00%$0 MOct 15, 2026
15Osaic Holdings, Inc.500 (0.00%)0.00%$0 MNov 12, 2026
16Winch Advisory Services, LLC260 (0.00%)0.00%$0 MNov 6, 2026
17TFC Financial Management, Inc.190 (0.00%)0.00%$0 MOct 26, 2026
18IFG Advisory, LLC130 (0.00%)0.00%$0 MNov 9, 2026

Mutual funds holding Pluri Inc.#

2 funds hold shares worth $0 M. Since their previous reports 0 added shares and 0 sold.
Mutual funds holding Pluri Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC2,751$0 M—<0.01%no changeMay 31, 2026
🇺🇸 Dimensional International Small Cap ETFDimensional Fund Advisors LP1$0 M—<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 2 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Pluri Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$1.3 M
1 purchase, 1 insider
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$1.3 M
open market only
Insiders on file
23
since
$4.5 M$0Apr 2025: bought $4.5 M (3 trades), sold $0 (0 trades)Apr 25Oct 2026: bought $1.3 M (1 trades), sold $0 (0 trades)Oct
Bought (open market)Sold (open market)Hover a month for the totals
Pluri Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Alexandre Weinstein ManieuDirector, 10% ownerBuyindirect+833,334$1.500$1.3 M2.08 MForm 4
filed Alexandre Weinstein ManieuDirector, 10% ownerOption exercise+641——7,566Form 4
filed Alexandre Weinstein ManieuDirector, 10% ownerGrant or award+180,000——190,769Form 4
filed Doron ShorrerDirectorGrant or award+31,569——38,228Form 4
filed Alexandre Weinstein ManieuDirector, 10% ownerGrant or award+641——6,925Form 4
filed Alexandre Weinstein ManieuDirector, 10% ownerGrant or awardindirect+312,500$2.000$625 K1.25 MForm 4
filed Alexandre Weinstein ManieuDirector, 10% ownerGrant or awardindirect+312,500$2.000$625 K937,500Form 4
filed Chutzpah Holdings Ltd10% ownerGrant or awardindirect+625,000$2.000$1.3 M625,000Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Pluri Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
76,809
0.7% of shares · 1 days to cover
Shares sold short, last 24 reportsAll stocks →

Trading halts

  • 2026-05-19 13:32 UTC, code LUDP, resumed 13:37 UTC
  • 2026-02-13 19:24 UTC, code LUDP, resumed 19:29 UTC
  • 2025-09-10 15:26 UTC, code LUDP, resumed 15:31 UTC
  • 2025-08-22 19:55 UTC, code LUDP, resumed 20:00 UTC
  • 2025-06-23 18:57 UTC, code LUDP, resumed 19:07 UTC

Fails to deliver

  • : 3,359 shares at $1.23
  • : 501 shares at $1.12
  • : 152 shares at $1.01
  • : 324 shares at $1.25
  • : 101 shares at $1.26

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Pluri Inc. scorecard#

Passes 3 of the 17 checks that could be worked out: strongest in growth (3 of 5), weakest in valuation (0 of 5). Fiscal year 2026; market cap of Oct 29, 2026.

  • Valuation0 of 5
  • Growth3 of 5
  • Profitability0 of 2
  • Financial health0 of 4
  • Shareholder returns0 of 1

Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 20, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Pluri Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Pluri Inc.: statements by fiscal year
PeriodTrendFY 2026to Jun 30, 2026FY 2025to Jun 30, 2025FY 2024to Jun 30, 2024FY 2023to Jun 30, 2023FY 2022to Jun 30, 2022FY 2021to Jun 30, 2021FY 2020to Jun 30, 2020FY 2019to Jun 30, 2019FY 2018to Jun 30, 2018FY 2017to Jun 30, 2017
Income statement
Revenue1.01.30.30.30.2—0.00.10.1—
Cost of revenue0.60.70.00.0———0.00.0—
Gross profit0.50.70.30.30.2—0.00.10.0—
Research and development15131216r253123302624
General and administrative1010.0101217217.99.2116.9
Operating income−25−22−22−27−42−51−29−36−34−28
Interest and finance income0.51.11.4———————
Interest expense and finance costs0.90.90.90.80.90.1————
Other non-operating income (expense)−0.5−1.10.8−1.60.20.80.30.27.60.2
Income before tax−25−23−21———————
Income tax−0.0−0.0————————
Net income including minority interests−25−23−21−29−41−50r————
Minority interests' share of net income−1.5−0.7−0.5−0.6−0.1—————
Net income attributable to shareholders−24−23−21−28−41−50−29−35−26−28
Earnings per share, basic-2.44-3.56-3.99-6.24r-1.28-1.77-1.60-2.90-2.50r-3.20r
Earnings per share, diluted-2.44-3.56-3.99-6.24r-1.28-1.77-1.60-2.90-2.50r-3.20r
Shares, weighted average (basic)9.76.35.24.6r3228————
Shares, weighted average (diluted)9.76.35.24.6r3228181211r8.7r
Balance sheet
Cash and cash equivalents3.55.96.85.49.8318.34.18.84.7
Short-term investments—————343820216.2
Receivables————0.00.0——0.11.0
Other current assets0.80.80.8r1.01.71.82.12.01.4r1.3
Current assets8.7223141586748263229
Property, plant and equipment1.61.80.70.70.71.52.53.85.77.3
Right-of-use (leased) assets6.26.96.67.68.30.71.3———
Goodwill3.13.1————————
Other intangible assets2.62.8————————
Long-term investments—————2312r0.40.40.4
Non-current assets16178.49.41026174.96.98.5
Total assets25394051689466313938
Accounts payable0.70.91.01.81.82.52.02.33.32.0
Current liabilities33324.55.66.8128.08.28.55.4
Long-term debt——————1.3———
Lease liabilities (non-current)6.56.15.05.76.50.10.6———
Non-current liabilities9.67.2303029251.41.31.91.9
Retained earnings−467−443−420−400−371−330−280−251−216−190
Shareholders' equity−23−6.80.113305756222930
Minority interests5.66.05.31.92.1—————
Total equity−17−0.95.415325756———
Total liabilities and equity25394051689466313938
Shares outstanding117.95.45.2r3332251511r97
Cash-flow statement
Depreciation and amortization0.50.30.3———————
Share-based compensation3.72.12.64.08.9142.65.16.53.7
Cash from operating activities−20−18−18−23−37−31−26−29−21−22
Capital expenditure−0.6−1.6−0.3−0.3−0.3−0.4−0.3−0.2−0.3−0.4
Acquisitions, net of cash acquired—————−0.0−0.0———
Cash from investing activities9.98.0119.712−7.3−301.25.7r4.4r
Shares issued5.19.60.18.0—3758231916
Cash from financing activities7.09.58.88.07.56161242016
Exchange-rate effect on cash0.00.20.0−0.0−3.2r−0.1r————
Change in cash−2.6−0.51.4−5.2−20234.0—4.1−1.5
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Executive pay at Pluri Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$1.5 M
Yaky Yanay
Other top executives, average
$590 K
the CEO earned 2.5× this
$100 invested is now
—
Pluri Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Yaky Yanay$1.5 M$577 K$590 K—
2024Yaky Yanay$741 K$307 K——
2023Yaky Yanay$2.6 M−$238 K——

Source: SEC proxy statement (Form DEF 14A) · as of Jun 30, 2025

Events at Pluri Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Delisting noticeFiling
  • Delisting noticeFiling
  • Delisting noticeFiling
  • Delisting noticeFiling
  • Delisting noticeFiling

Delisting notice 5 · Directors and officers 6 · Material agreement 10 · Unregistered share sale 9 · Shareholder vote 2

Pluri Inc.: events reported to the SEC
FiledWhat happenedFiling
Material agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Delisting notice8-K
Directors and officersMaterial agreementShareholder vote8-K
Material agreementUnregistered share sale8-K
Delisting notice8-K
Directors and officersMaterial agreementUnregistered share sale8-K
Directors and officers8-K
Directors and officers8-K
Delisting noticeDirectors and officersShareholder vote8-K
Material agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Directors and officersMaterial agreementUnregistered share sale8-K
Delisting notice8-K
Delisting notice8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Oct 30, 2026

Acquisitions and funding#

1 acquisitions, $6 M paid where reported · 1 private funding rounds before listing

Businesses it acquired

Acquisitions by Pluri Inc.
AcquiredAcquisition dateCompletionPriceStakeSource
Kokomodo Transaction2025—$6 M—Annual report

Private share sales · funding history

Private share sales of Pluri Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2026$4 MPrivate placement after listing$2 to $10 million1optionsSEC
Feb 2025$4 MPrivate placement after listing$2 to $10 million1equity, optionsSEC
Dec 2022$8 MPrivate placement after listing$2 to $10 million14equity, optionsSEC
Oct 2010$1 MNo. 1Under $2 million9equity, optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its annual reports since 2010, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

How Pluri Inc. compares in Biotechnology

  • Market cap$15 M · higher than 15% of 726
  • Revenue$1 M · higher than 25% of 647
  • Revenue growth-23.9% · higher than 29% of 438
  • Price / sales10.4× · lower than 43% of 339
  • FCF yield-133.2% · higher than 6% of 449

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Pluri Inc.🇮🇱$15 M——-23.9%
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 29, 2026
Annual results:
For year ending June-2026
Balance sheet:
As of June-2026
Employees:
As of June 30, 2026
Profile updated:
Nov 21, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Pluri Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Pluri Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Pluri Inc.? Suggest a correction